Researchers analyzed an extensive survey of U.S. adults, finding that irritability is common and strongly associated with higher risks of depression, anxiety, and suicidal thoughts, particularly ...

Psychological signs, like anxiety and irritability, typically show up before physical ones like hot flashes, night sweats and ...

The Phase II trial comes as the US Food and Drug Administration grants an investigational new drug application for cannabis therapy AJA001.

Caffeine withdrawal may cause headaches, irritability, low energy, and mood changes. It's important to understand how your body might respond if you are considering giving up caffeine or reducing ...

An investigational cannabinoid (CBD) derived therapy is advancing to a Phase II trial to investigate its effects on irritability stemming from autism spectrum disorder (ASD) in children and adults.